Inhibition of effectorT lymphocytes mediated through antagonism of IL-4 [2]

Journal of Allergy and Clinical Immunology

Volumn 113, Issue 3, 2004, Pages 560-562

  Enelow, Richard ^a   Baramki, Dawn F ^a   Borish, Larry C ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; CYTOKINE; INTERLEUKIN 4 RECEPTOR;

APOPTOSIS; ASTHMA; BRONCHOSCOPY; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; EFFECTOR CELL; HELPER CELL; HUMAN; LETTER; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; BIOSYNTHESIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; SOLUBILITY; TH1 CELL; TH2 CELL;

APOPTOSIS; CELL DIFFERENTIATION; CYTOKINES; HUMANS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN-4; SOLUBILITY; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 1542615819     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2003.12.004     Document Type: Letter

References (5)

1. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 1998;95:3810-5.
2. Vella AT, Teague TK, Ihle J, Kappler J, Marrack P. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med 1997;186:325-30.
3. Stack RM, Thompson CB, Fitch FW. IL-4 enhanced long-term survival of CD28-deficient T cells. J Immunol 1998;160:2255-62.
4. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal and asthmatic subjects. J Allergy Clin Immunol 1996;97:1288-96.
5. Wells AD, Walsh MC, Bluestone JA, Turka LA. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest 2001;108:895-904.